» Articles » PMID: 38667178

Colorimetric and Electrochemical Dual-Mode Detection of Thioredoxin 1 Based on the Efficient Peroxidase-Mimicking and Electrocatalytic Property of Prussian Blue Nanoparticles

Overview
Specialty Biotechnology
Date 2024 Apr 26
PMID 38667178
Authors
Affiliations
Soon will be listed here.
Abstract

As a potent detection method for cancer biomarkers in physiological fluid, a colorimetric and electrochemical dual-mode sensing platform for breast cancer biomarker thioredoxin 1 (TRX1) was developed based on the excellent peroxidase-mimicking and electrocatalytic property of Prussian blue nanoparticles (PBNPs). PBNPs were hydrothermally synthesized using K[Fe(CN)] as a precursor and polyvinylpyrrolidone (PVP) as a capping agent. The synthesized spherical PBNPs showed a significant peroxidase-like activity, having approximately 20 and 60% lower values for 3,3',5,5'-tetramethylbenzidine (TMB) and HO, respectively, compared to those of horseradish peroxidase (HRP). The PBNPs also enhanced the electron transfer on the electrode surface. Based on the beneficial features, PBNPs were used to detect target TRX1 via sandwich-type immunoassay procedures. Using the strategies, TRX1 was selectively and sensitively detected, yielding limit of detection (LOD) values as low as 9.0 and 6.5 ng mL via colorimetric and electrochemical approaches, respectively, with a linear range of 10-50 ng mL in both strategies. The PBNP-based TRX1 immunoassays also exhibited a high degree of precision when applied to real human serum samples, demonstrating significant potentials to replace conventional HRP-based immunoassay systems into rapid, robust, reliable, and convenient dual-mode assay systems which can be widely utilized for the identification of important target molecules including cancer biomarkers.

Citing Articles

Nanozyme-based aptasensors for the detection of tumor biomarkers.

Wang K, Lin X, Lv X, Xie M, Wu J, Wu J J Biol Eng. 2025; 19(1):13.

PMID: 39920818 PMC: 11806818. DOI: 10.1186/s13036-025-00485-0.


Overview of the Design and Application of Dual-Signal Immunoassays.

Ma X, Ge Y, Xia N Molecules. 2024; 29(19).

PMID: 39407482 PMC: 11477509. DOI: 10.3390/molecules29194551.

References
1.
Farka Z, cunderlova V, Horackova V, Pastucha M, Mikusova Z, Hlavacek A . Prussian Blue Nanoparticles as a Catalytic Label in a Sandwich Nanozyme-Linked Immunosorbent Assay. Anal Chem. 2018; 90(3):2348-2354. DOI: 10.1021/acs.analchem.7b04883. View

2.
Busquets M, Estelrich J . Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications. Drug Discov Today. 2020; 25(8):1431-1443. DOI: 10.1016/j.drudis.2020.05.014. View

3.
Xu Y, Zhang Y, Cai X, Gao W, Tang X, Chen Y . Large-scale synthesis of monodisperse Prussian blue nanoparticles for cancer theranostics via an "in situ modification" strategy. Int J Nanomedicine. 2019; 14:271-288. PMC: 6312061. DOI: 10.2147/IJN.S183858. View

4.
Zhang W, Ma D, Du J . Prussian blue nanoparticles as peroxidase mimetics for sensitive colorimetric detection of hydrogen peroxide and glucose. Talanta. 2014; 120:362-7. DOI: 10.1016/j.talanta.2013.12.028. View

5.
Jia J, Geng W, Wang Z, Chen L, Zeng X . The role of thioredoxin system in cancer: strategy for cancer therapy. Cancer Chemother Pharmacol. 2019; 84(3):453-470. DOI: 10.1007/s00280-019-03869-4. View